Subdermal Implant-bioabsorbable Oxandrolone Pellet For Rehabilitation Following Anterior Cruciate Ligament (ACL) Surgical Reconstruction

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

96

Participants

Timeline

Start Date

June 16, 2025

Primary Completion Date

May 11, 2026

Study Completion Date

May 11, 2026

Conditions
Anterior Cruciate Ligament (ACL) Reconstruction
Interventions
DRUG

Oxandrolone

Absorbable oxandrolone implant (subdermal insertion) Men: 400 mg oxandrolone (two 200 mg oxandrolone implants each) Women: 200 mg oxandrolone (one 200 mg oxandrolone implant)

DRUG

Placebo

Absorbable placebo implant (excipients; subdermal insertion) Men: 400 mg placebo (two 200 mg placebo implants each) Women: 200 mg placebo (one 200 mg placebo implant)

Trial Locations (1)

Unknown

Science Valley Research Institute, São Paulo, Sao Paulo, São Paulo

All Listed Sponsors
collaborator

Stin Pharma

UNKNOWN

lead

Science Valley Research Institute

OTHER